Clinical Trials · NCT06606821
The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Tina Vilsbøll
- Enrollment
- 124
- Start date
- Oct 2024
- Locations
- 3 sites, Denmark
- Primary endpoint
- Lipid core burden index